Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]

Tan S, Zeng Y, Kuang S, Li J. Diabetes Metab Syndr Obes. 2021;14:1601–1608. The Editor and Publisher of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy wish to retract the published article. Concerns were raised over a discrepancy in the ethics statement and patient cohort lo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tan S, Zeng Y, Kuang S, Li J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	biomarker chronic kidney disease human epididymis protein 4. Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/76d4ba0d17794883812e1fd5653de566
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:76d4ba0d17794883812e1fd5653de566
record_format	dspace
spelling	oai:doaj.org-article:76d4ba0d17794883812e1fd5653de5662021-12-02T18:55:10ZSerum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]1178-7007https://doaj.org/article/76d4ba0d17794883812e1fd5653de5662021-10-01T00:00:00Zhttps://www.dovepress.com/retraction-serum-human-epididymis-protein-4-is-a-potential-biomarker-f-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Tan S, Zeng Y, Kuang S, Li J. Diabetes Metab Syndr Obes. 2021;14:1601–1608. The Editor and Publisher of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy wish to retract the published article. Concerns were raised over a discrepancy in the ethics statement and patient cohort location reported in the article. The ethics committee who approved the study was reported as the Ethics Committee of Renmin Hospital of Weihai Central Hospital and the location of the patient cohort was described as Weihai Central Hospital. These were not the same as the Second Affiliated Hospital of the University of South China from which the authors were affiliated. The authors explained an error had been made and the Ethics Committee of the Second Affiliated Hospital of the University of South China approved the study and the cohort consisted of patients from the Second Affiliated Hospital of the University of South China. However, the authors were unable to provide a satisfactory explanation for why the misreporting had occurred and could not provide the original ethical review documents from the Ethics Committee of the Second Affiliated Hospital of the University of South China. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paperTan SZeng YKuang SLi JDove Medical Pressarticlebiomarkerchronic kidney diseasehuman epididymis protein 4.Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 4179-4180 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	biomarker chronic kidney disease human epididymis protein 4. Specialties of internal medicine RC581-951
spellingShingle	biomarker chronic kidney disease human epididymis protein 4. Specialties of internal medicine RC581-951 Tan S Zeng Y Kuang S Li J Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]
description	Tan S, Zeng Y, Kuang S, Li J. Diabetes Metab Syndr Obes. 2021;14:1601–1608. The Editor and Publisher of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy wish to retract the published article. Concerns were raised over a discrepancy in the ethics statement and patient cohort location reported in the article. The ethics committee who approved the study was reported as the Ethics Committee of Renmin Hospital of Weihai Central Hospital and the location of the patient cohort was described as Weihai Central Hospital. These were not the same as the Second Affiliated Hospital of the University of South China from which the authors were affiliated. The authors explained an error had been made and the Ethics Committee of the Second Affiliated Hospital of the University of South China approved the study and the cohort consisted of patients from the Second Affiliated Hospital of the University of South China. However, the authors were unable to provide a satisfactory explanation for why the misreporting had occurred and could not provide the original ethical review documents from the Ethics Committee of the Second Affiliated Hospital of the University of South China. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
format	article
author	Tan S Zeng Y Kuang S Li J
author_facet	Tan S Zeng Y Kuang S Li J
author_sort	Tan S
title	Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]
title_short	Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]
title_full	Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]
title_fullStr	Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]
title_full_unstemmed	Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]
title_sort	serum human epididymis protein 4 is a potential biomarker for early chronic kidney disease in an obese population [retraction]
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/76d4ba0d17794883812e1fd5653de566
work_keys_str_mv	AT tans serumhumanepididymisprotein4isapotentialbiomarkerforearlychronickidneydiseaseinanobesepopulationretraction AT zengy serumhumanepididymisprotein4isapotentialbiomarkerforearlychronickidneydiseaseinanobesepopulationretraction AT kuangs serumhumanepididymisprotein4isapotentialbiomarkerforearlychronickidneydiseaseinanobesepopulationretraction AT lij serumhumanepididymisprotein4isapotentialbiomarkerforearlychronickidneydiseaseinanobesepopulationretraction
_version_	1718377274785398784

Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population [Retraction]

Ejemplares similares